Emilia M Swietlik
Overview
Explore the profile of Emilia M Swietlik including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
32
Citations
728
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Swietlik E, Fay M, Morrell N
Respiration
. 2024 Sep;
104(1):26-39.
PMID: 39250896
Introduction: Establishing a diagnosis is paramount in medical practice as it shapes patients' experiences and guides treatment. Patients grappling with rare diseases face a triple challenge: prolonged diagnostic journeys, limited...
2.
Swietlik E, Fay M, Morrell N
Pulm Circ
. 2024 Mar;
14(1):e12353.
PMID: 38482173
Genetic research and testing are increasingly important for understanding and treating pulmonary arterial hypertension. We aimed to explore how attitudes toward genetic research among clinical and research teams impacted the...
3.
Swietlik E, Fay M, Morrell N
Pulm Circ
. 2024 Feb;
14(1):e12346.
PMID: 38361979
Genetic research's growing importance in understanding pulmonary arterial hypertension (PAH) and developing effective treatments prompted the RAPID-PAH study. This study sought feedback from stakeholders who participated in two genomic studies...
4.
Ulrich A, Wu Y, Draisma H, Wharton J, Swietlik E, Cebola I, et al.
Nat Commun
. 2024 Jan;
15(1):330.
PMID: 38184627
Pulmonary arterial hypertension (PAH) is characterised by pulmonary vascular remodelling causing premature death from right heart failure. Established DNA variants influence PAH risk, but susceptibility from epigenetic changes is unknown....
5.
Carmody L, Gargano M, Toro S, Vasilevsky N, Adam M, Blau H, et al.
Med
. 2023 Nov;
4(12):913-927.e3.
PMID: 37963467
Background: Navigating the clinical literature to determine the optimal clinical management for rare diseases presents significant challenges. We introduce the Medical Action Ontology (MAxO), an ontology specifically designed to organize...
6.
Carmody L, Gargano M, Toro S, Vasilevsky N, Adam M, Blau H, et al.
medRxiv
. 2023 Jul;
PMID: 37503136
Navigating the vast landscape of clinical literature to find optimal treatments and management strategies can be a challenging task, especially for rare diseases. To address this task, we introduce the...
7.
Reddy S, Swietlik E, Robertson L, Michael A, Boyle S, Polwarth G, et al.
J Heart Lung Transplant
. 2023 May;
42(9):1275-1285.
PMID: 37201688
Background: We describe baseline characteristics, disease progression and mortality in chronic thromboembolic pulmonary disease patients as a function of mean pulmonary artery pressure (mPAP) according to new and previous definitions...
8.
Hadinnapola C, Southwood M, Hernandez-Sanchez J, Bunclark K, Newnham M, Swietlik E, et al.
J Heart Lung Transplant
. 2023 Jan;
42(3):398-405.
PMID: 36609091
Introduction: Chronic thromboembolic pulmonary hypertension (CTEPH) is an underdiagnosed disease of uncertain etiology. Altered endothelial homeostasis, defective angiogenesis and inflammation are implicated. Angiopoietin 2 (Ang2) impairs acute thrombus resolution and...
9.
Kariotis S, Jammeh E, Swietlik E, Pickworth J, Rhodes C, Otero P, et al.
Nat Commun
. 2022 Nov;
13(1):7276.
PMID: 36433938
No abstract available.
10.
MacLean M, Pandya D, Swietlik E, Denver N, Mair K, Morrell N, et al.
Pulm Circ
. 2022 Oct;
12(3):e12139.
PMID: 36186719
The hypothesis that a relationship exists between body mass index (BMI), functional class, and 6 min walk distance (6MWD) in Group 1-pulmonary arterial hypertension (PAH) was examined. Analysis of data...